Please Wait.....
Report
U.S. Induced Pluripotent Stem Cells (iPSCs) Market - Industry Trends and Forecast to 2031
Market Report I 2023-12-01 I 100 Pages I Data Bridge Market Research
The U.S. induced pluripotent stem cells (iPSCs) market is expected to reach USD 488.42 million by 2031 from USD 218.87 million in 2023, growing at a CAGR of 10.7% in the forecast period of 2024 to 2031.
Market Segmentation
U.S. Induced Pluripotent Stem Cells (iPSCs) Market, By Model Type (ECM-Patterned PAA/ PDMS Substrates, Microgroove PDMS Substrates, Strained Membranes, 3D Sacffolds, Free-Floating Hydrogel Contructs, and EHTS), Material (Natural Hydrogel Based Cardiac Models and Synthetic Fibrous Cardiac Models), Cell Source (Skin Cells and Blood Cells), Dimensional Type (2D and 3D), Application (Production of New Cardiac Tissue To Replace Tissue Destroyed By Infraction Or Other Diseases, Heart Failure, Ischemic Heart Disease, Arrhythmia, Cardiomyopathies, Valvular Heart Disease, Heart Disease Screening, and Others), End Use (Pharmaceutical & Biotechnology Companies, Academic and Government Research Institutes, Contract Development & Manufacturing Organizations, and Others ), Distribution Channel (Direct Tender and Retail Sales) Country (U.S.) - Industry Trends and Forecast to 2031
Overview of U.S. Induced Pluripotent Stem Cells (iPSCs) Market Dynamics
Driver
- Technological advancement in regenerative medicine
Restraint
- Safety concerns and technical difficulties
Opportunity
- Increasing interest in personalized medicine
Market Players
Some of the major market players operating in the U.S. induced pluripotent stem cells (iPSCs) market are:
- Corning Incorporated
- Lonza
- MIMETAS
- CN Bio Innovations Ltd
- 3D BIOTEK LLC
- AXOL
- REPROCELL Inc.
TABLE OF CONTENTS
1 INTRODUCTION 11
1.1 OBJECTIVES OF THE STUDY 11
1.2 MARKET DEFINITION 11
1.3 OVERVIEW OF U.S. INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET 11
1.4 CURRENCY AND PRICING 12
1.5 LIMITATIONS 12
1.6 MARKETS COVERED 13
2 MARKET SEGMENTATION 15
2.1 MARKETS COVERED 15
2.2 YEARS CONSIDERED FOR THE STUDY 16
2.3 DBMR TRIPOD DATA VALIDATION MODEL 17
2.4 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 20
2.5 DBMR MARKET POSITION GRID 21
2.6 MULTIVARIATE MODELLING 22
2.7 TYPE LIFELINE CURVE 23
2.8 MARKET END USER COVERAGE GRID 24
2.9 SECONDARY SOURCES 25
2.10 ASSUMPTIONS 25
3 EXECUTIVE SUMMARY 26
4 PREMIUM INSIGHTS 29
4.1 PESTEL ANALYSIS 30
4.2 PORTER'S FIVE FORCES 31
5 MARKET OVERVIEW 32
5.1 DRIVERS 34
5.1.1 TECHNOLOGICAL ADVANCEMENT IN REGENERATIVE MEDICINE 34
5.1.2 EXPANDING APPLICATIONS IN DRUGS DISCOVERY 34
5.2 RESTRAINTS 35
5.2.1 SAFETY CONCERNS AND TECHNICAL DIFFICULTIES 35
5.2.2 COMPETITION AND INTELLECTUAL PROPERTY ISSUES 36
5.3 OPPORTUNITIES 36
5.3.1 INCREASING INTEREST OF PERSONALIZED MEDICINE 36
5.3.2 INCREASING ADOPTION OF STEM CELL THERAPY 37
5.4 CHALLENGE 38
5.4.1 HIGH COST ASSOCIATED WITH STEM CELL THERAPIES 38
?
6 U.S. INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET, BY MODEL TYPE 39
6.1 OVERVIEW 40
6.2 ECM PATTERNED PAA/PDMS SUBSTRATES 43
6.3 MICROGROOVE PDMS SUBSTRATES 43
6.4 STRAINED MEMBRANES 43
6.5 3D SACFFOLDS 43
6.6 FREE-FLOATING HYDROGEL CONTRUCTS 43
6.7 EHTS 43
7 U.S. INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET, BY MATERIAL 44
7.1 OVERVIEW 45
7.2 NATURAL HYDROGEL- BASED CARDIAC MODELS 48
7.3 SYNTHETICS FIBROUS CARDIAC MODELS 48
7.3.1 POLYGLYCOLIC ACID (PGA) 48
7.3.2 POLY E-CAPROLACTONE (PCL) 48
7.3.3 POLYURETHANE 48
7.3.4 POLYLACTIC ACID (PLA) 49
7.3.5 OTHERS 49
8 U.S. INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET, BY CELL SOURCE 50
8.1 OVERVIEW 51
8.2 SKIN CELLS 54
8.2.1 FIBROBLAST 54
8.2.2 KERATINOCYTES 54
8.2.3 MELANOCYTES 54
8.2.4 NEURAL STEM CELLS 54
8.2.5 ADIPOSE DERIVE STEM CELLS 54
8.2.6 OTHERS 55
8.3 BLOOD CELLS 55
8.3.1 PERIPHERAL BLOOD MONOCLEAR CELLS 55
8.3.2 CORD BLOOD ENDOTHELIAL CELLS 55
8.3.3 CORD BLOOD STEM CELLS 55
8.3.4 OTHERS 55
9 U.S. INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET, BY DIMENSIONAL TYPE 56
9.1 OVERVIEW 57
9.2 3D 60
9.3 SKIN CELLS 60
9.3.1 FIBROBLAST 60
9.3.2 KERATINOCYTES 61
9.3.3 MELANOCYTES 61
9.3.4 NEURAL STEM CELLS 61
9.3.5 ADIPOSE DERIVE STEM CELLS 61
9.3.6 OTHERS 61
9.4 BLOOD CELLS 61
9.4.1 PERIPHERAL BLOOD MONOCLEAR CELLS 62
9.4.2 CORD BLOOD ENDOTHELIAL CELLS 62
9.4.3 CORD BLOOD STEM CELLS 62
9.4.4 OTHERS 62
9.5 2D 62
9.5.1 SKIN CELLS 62
9.5.1.1 FIBROBLAST 63
9.5.1.2 KERATINOCYTES 63
9.5.1.3 MELANOCYTES 63
9.5.1.4 NEURAL STEM CELLS 63
9.5.1.5 ADIPOSE DERIVE STEM CELLS 63
9.5.1.6 OTHERS 63
9.5.2 BLOOD CELLS 64
9.5.2.1 PERIPHERAL BLOOD MONOCLEAR CELLS 64
9.5.2.2 CORD BLOOD ENDOTHELIAL CELLS 64
9.5.2.3 CORD BLOOD STEM CELLS 64
9.5.2.4 OTHERS 64
10 U.S. INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET, BY APPLICATION 65
10.1 OVERVIEW 66
10.2 PRODUCTION OF NEW CARDIAC TISSUE TO REPLACE TISSUES DESTROYED BY INFRACTION OR OTHER DISEASES 70
10.3 HEART FAILURE 70
10.4 ISCHEMIC HEART DISEASE 70
10.5 ARRYTHMIA 70
10.6 CARDIOMYOPATHIES 70
10.7 VALVULAR HEART DISEASE 70
10.8 HEART DISEASE SCREENING 70
10.9 OTHERS 70
11 U.S. INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET, BY END USE 71
11.1 OVERVIEW 72
11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 75
11.3 ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES 75
11.4 CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS 75
11.5 OTHERS 75
12 U.S. INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET, BY DISTRIBUTION CHANNEL 76
12.1 OVERVIEW 77
12.2 DIRECT TENDER 80
12.3 RETAIL SALES 80
13 U.S. INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET: COMPANY LANDSCAPE 81
13.1 COMPANY SHARE ANALYSIS: U.S. 81
14 SWOT ANALYSIS 82
15 COMPANY PROFILE 83
15.1 CORNING INCRPORATED 83
15.1.1 COMPANY SNAPSHOT 83
15.1.2 REVENUE ANALYSIS 83
15.1.3 PRODUCT PORTFOLIO 84
15.1.4 RECENT DEVELOPMENT 85
15.2 LONZA 86
15.2.1 COMPANY SNAPSHOT 86
15.2.2 REVENUE ANALYSIS 86
15.2.3 PRODUCT PORTFOLIO 87
15.2.4 RECENT DEVELOPMENT 88
15.3 MIMETAS 89
15.3.1 COMPANY SNAPSHOT 89
15.3.2 PRODUCT PORTFOLIO 89
15.3.3 RECENT DEVELOPMENT 89
15.4 REPROCELL INC. 90
15.4.1 COMPANY SNAPSHOT 90
15.4.2 PRODUCT PORTFOLIO 90
15.4.3 RECENT DEVELOPMENT 91
15.5 CN BIO INNOVATIONS 92
15.5.1 COMPANY SNAPSHOT 92
15.5.2 PRODUCT PORTFOLIO 92
15.5.3 RECENT DEVELOPMENT 93
15.6 AXOL BIOSCIENCE LTD. 94
15.6.1 COMPANY SNAPSHOT 94
15.6.2 PRODUCT PORTFOLIO 94
15.6.3 RECENT DEVELOPMENT 94
15.7 3D BIOTEK LLC. 95
15.7.1 COMPANY SNAPSHOT 95
15.7.2 PRODUCT PORTFOLIO 95
15.7.3 RECENT DEVELOPMENT 96
16 QUESTIONNAIRE 97
17 RELATED REPORTS 100
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security